Safety, Pharmacokinetics, and Preliminary Efficacy of BYON4413 in Acute Myeloid Leukemia and Myelodysplastic Neoplasms.
Clinical trial NCT06359002 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06359002
- Sponsor
- Byondis B.V.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-25
- Primary completion
- 2025-09-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.